Document is current
Any future updates will be listed below
-
Authors
Pinello, Natalia
Song, Renhua
Lee, Quintin
Calonne, Emilie
Duan, Kun-Long
Wong, Emilie
Tieng, Jessica
Mehravar, Majid
Rong, Bowen
Lan, Fei
Roediger, Ben
Ma, Cheng-Jie
Yuan, Bi-Feng
Rasko, John E. J.
Larance, Mark
Ye, Dan
Fuks, François
Wong, Justin J.-L. https://orcid.org/0000-0002-7038-5079
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (1126306, 1128175, 1128175, 1177305, 1191613)
University of Sydney
Sydney Catalyst
Arrow Bone Marrow Transplant Foundation
Cancer Institute NSW (2018/CDF002, 2105/ECF113)
University of Sydney
- License Information
-
More Information
Article History
Received: 6 February 2024
Revised: 27 April 2024
Accepted: 1 May 2024
First Online: 23 May 2024
Declarations
:
: B.R. is a current employee of Novartis Pharma AG. Novartis did not fund the study.
: Not applicable.
: Not applicable.
